C18 Lactosyl(beta) Ceramide (d18:1/18:0)
| Catalog Number | BL-M001076 |
| CAS Number | 125712-73-4 |
| Description | C18 Lactosyl(beta) Ceramide (d18:1/18:0) This product is a ceramide compound that plays a role in the treatment of various diseases, including cancer and neurodegenerative disorders. It has potential therapeutic applications in drug delivery and targeted therapy for specific cell types within the biomedical field. |
| IUPAC Name | N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]octadecanamide |
| Synonyms | D-lactosyl-beta-1,1' N-stearoyl-D-erythro-sphingosine; C18 beta-D-Lactosyl Ceramide; Lactosylceramide; beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-octadecanoylsphingosine; LacCer(d18:1/18:0) |
| Molecular Weight | 890.24 |
| Molecular Formula | C48H91NO13 |
| Boiling Point | 1001.4±65.0 °C(Predicted) |
| Purity | >99% |
| Density | 1.14±0.1 g/cm3(Predicted) |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 64.76%, H 10.30%, N 1.57%, O 23.36% |
| Canonical SMILES | CCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O |
| InChI | InChI=1S/C48H91NO13/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(53)49-36(37(52)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2)35-59-47-45(58)43(56)46(39(34-51)61-47)62-48-44(57)42(55)41(54)38(33-50)60-48/h29,31,36-39,41-48,50-52,54-58H,3-28,30,32-35H2,1-2H3,(H,49,53)/b31-29+/t36-,37+,38+,39+,41-,42-,43+,44+,45+,46+,47+,48-/m0/s1 |
| InChI Key | VOZHMDQUIRUFQW-LOTHNZFDSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
